{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:47:24Z","timestamp":1790102844260,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12282-025-01668-9","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T01:44:10Z","timestamp":1740447850000},"page":"470-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer: a prospective follow-up study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8461-5613","authenticated-orcid":false,"given":"Shu-I","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Chin-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Show","family":"Tzang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Kuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"1668_CR1","unstructured":"U.S. Breast Cancer Statistics [https:\/\/www.breastcancer.org\/facts-statistics]"},{"issue":"10","key":"1668_CR2","first-page":"1647","volume":"19","author":"CE Jansen","year":"2011","unstructured":"Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer\u202f: Off J Multinat Assoc Support Care Cancer. 2011;19(10):1647\u201356.","journal-title":"Support Care Cancer : Off J Multinat Assoc Support Care Cancer"},{"key":"1668_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fonc.2015.00059","volume":"5","author":"M Ono","year":"2015","unstructured":"Ono M, Ogilvie JM, Wilson JS, Green HJ, Chambers SK, Ownsworth T, Shum DH. A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Front Oncol. 2015;5:59.","journal-title":"Front Oncol"},{"issue":"1","key":"1668_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10549-017-4376-4","volume":"166","author":"C Yao","year":"2017","unstructured":"Yao C, Bernstein LJ, Rich JB. Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review. Breast Cancer Res Treat. 2017;166(1):15\u201328.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1668_CR5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","volume":"26","author":"YT Cheung","year":"2015","unstructured":"Cheung YT, Ng T, Shwe M, Ho HK, Foo KM, Cham MT, Lee JA, Fan G, Tan YP, Yong WS, et al. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Ann Oncol\u202f: Off J Eur Soc Med Oncol. 2015;26(7):1446\u201351.","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"key":"1668_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.10.005","volume":"314","author":"AM Williams","year":"2018","unstructured":"Williams AM, Shah R, Shayne M, Huston AJ, Krebs M, Murray N, Thompson BD, Doyle K, Korotkin J, van Wijngaarden E, et al. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. J Neuroimmunol. 2018;314:17\u201323.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"1668_CR7","first-page":"3046","volume":"12","author":"Jingjing Zhao","year":"2020","unstructured":"Zhao Jingjing, Zuo He, Ding Ke, Zhang Xiuqing, Bi Ziran. Cheng H: Changes in plasma IL-1\u03b2, TNF-\u03b1 and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients. Am J Transl Res. 2020;12(6):3046\u201356.","journal-title":"Am J Transl Res"},{"issue":"1","key":"1668_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11682-017-9728-5","volume":"13","author":"JL Vardy","year":"2019","unstructured":"Vardy JL, Stouten-Kemperman MM, Pond G, Booth CM, Rourke SB, Dhillon HM, Dodd A, Crawley A, Tannock IF. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer. Brain Imaging Behav. 2019;13(1):15\u201326.","journal-title":"Brain Imaging Behav"},{"key":"1668_CR9","first-page":"11","volume":"13","author":"VC Chen","year":"2021","unstructured":"Chen VC, Lin CK, Hsiao HP, Tzang BS, Hsu YH, Wu SI. Stewart R: Effects of Cancer, Chemotherapy, and Cytokines on Subjective and Objective Cognitive Functioning Among Patients with Breast Cancer. Cancers (Basel). 2021;13:11.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1668_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13058-018-1062-3","volume":"20","author":"KD van der Willik","year":"2018","unstructured":"van der Willik KD, Koppelmans V, Hauptmann M, Compter A, Ikram MA, Schagen SB. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study. Breast Cancer Res: BCR. 2018;20(1):135.","journal-title":"Breast Cancer Res: BCR"},{"issue":"1","key":"1668_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s12282-020-01168-y","volume":"28","author":"YH Hsu","year":"2021","unstructured":"Hsu YH, Chen VC, Hsieh CC, Weng YP, Hsu YT, Hsiao HP, Wang WK, Chen HM, Weng JC, Wu SI, et al. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms. Breast Cancer (Tokyo, Japan). 2021;28(1):236\u201345.","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"Suppl","key":"1668_CR12","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.bbi.2012.07.015","volume":"30","author":"PA Ganz","year":"2013","unstructured":"Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DH, Geist C, Breen EC, Irwin MR, Cole SW. Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain, Behav Immunity. 2013;30(Suppl):S99-108.","journal-title":"Brain, Behav Immunity"},{"key":"1668_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2016.11.002","volume":"301","author":"DE Lyon","year":"2016","unstructured":"Lyon DE, Cohen R, Chen H, Kelly DL, McCain NL, Starkweather A, Ahn H, Sturgill J, Jackson-Cook CK. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol. 2016;301:74\u201382.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"1668_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/jnci\/djac022","volume":"114","author":"EK Belcher","year":"2022","unstructured":"Belcher EK, Culakova E, Gilmore NJ, Hardy SJ, Kleckner AS, Kleckner IR, Lei L, Heckler C, Sohn MB, Thompson BD, et al. Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy. J Nat Cancer Inst. 2022;114(5):712\u201321.","journal-title":"J Nat Cancer Inst"},{"issue":"2","key":"1668_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.22.00406","volume":"41","author":"JE Carroll","year":"2023","unstructured":"Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, et al. Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. J Clin Oncol\u202f: Off J Am Soc Clin Oncol. 2023;41(2):295\u2013306.","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"1","key":"1668_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13058-024-01850-5","volume":"26","author":"M Duivon","year":"2024","unstructured":"Duivon M, Lequesne J, Di Meglio A, Pradon C, Vaz-Luis I, Martin AL, Everhard S, Broutin S, Rigal O, Bousrih C, et al. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study. Breast Cancer Res\u202f: BCR. 2024;26(1):93.","journal-title":"Breast Cancer Res : BCR"},{"key":"1668_CR17","first-page":"1","volume":"1","author":"KHHMS Yang","year":"2015","unstructured":"Yang KHHMS. Color Trails Test (Chinese). Chinese Behav Sci Corp. 2015;1:1.","journal-title":"Chinese Behav Sci Corp"},{"issue":"6","key":"1668_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"1668_CR19","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85(5):1186\u201396.","journal-title":"Cancer"},{"issue":"3","key":"1668_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrc2073","volume":"7","author":"TA Ahles","year":"2007","unstructured":"Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007;7(3):192\u2013201.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1668_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1470-2045(10)70294-1","volume":"12","author":"JS Wefel","year":"2011","unstructured":"Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703\u20138.","journal-title":"Lancet Oncol"},{"key":"1668_CR22","first-page":"1","volume":"1","author":"MCB Hua","year":"2005","unstructured":"Hua MCB, Lin KN, Yang JM, Lu SR, Chen SY. Wechsler Memory Scale-Third Edition (Chinese). Chinese Behav Sci Corp. 2005;1:1.","journal-title":"Chinese Behav Sci Corp."},{"key":"1668_CR23","volume-title":"A normative study on the Color Trails Test in health middle age and elderly individuals in Taiwan","author":"HY Kuo","year":"2009","unstructured":"Kuo HY. A normative study on the Color Trails Test in health middle age and elderly individuals in Taiwan. Taipei: National Taiwan University; 2009."},{"key":"1668_CR24","volume-title":"A local normative study on semantic association of verbal fluency in healthy middle age and elderly individuals in North Taiwan","author":"CH Chen","year":"2010","unstructured":"Chen CH. A local normative study on semantic association of verbal fluency in healthy middle age and elderly individuals in North Taiwan. Taipei: National Taiwan University; 2010."},{"issue":"2","key":"1668_CR25","first-page":"187","volume":"50","author":"WH Wang","year":"2008","unstructured":"Wang WH, Hua MT, Yang CZ, et al. Taiwan WAIS-III Chinese version arithmetic, memory span test and its combined estimation: The clinical applicability of the working memory index: a retrospective study. Chinese J Psychol. 2008;50(2):187\u201399.","journal-title":"Chinese J Psychol"},{"issue":"3","key":"1668_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/WAD.0000000000000060","volume":"29","author":"YH Hsu","year":"2015","unstructured":"Hsu YH, Huang CF, Tu MC, Hua MS. Prospective memory in subjective cognitive decline: a preliminary study on the role of early cognitive marker in dementia. Alzheimer Dis Assoc Disord. 2015;29(3):229\u201335.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"1668_CR27","first-page":"365","volume":"49","author":"YL Wang","year":"2008","unstructured":"Wang YL, Hua MT, Chang WN, Lu CH, et al. A study on the perception of event memory in the elderly with Alzheimer\u2019s type dementia. Chinese J Psychol. 2008;49(4):365\u201382.","journal-title":"Chinese J Psychol"},{"key":"1668_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/WAD.0000000000000060","volume":"29","author":"Y Hsu","year":"2015","unstructured":"Hsu Y, Huang CF, Tu MC, Hua MS. Prospective memory in subjective cognitive decline: A preliminary study on the role of early cognitive marker in dementia. Alzheimer Dis Assoc Disord. 2015;29:229\u201335.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"1668_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1017\/S1355617720000405","volume":"26","author":"C Hogan","year":"2020","unstructured":"Hogan C, Cornwell P, Fleming J, Shum DHK. The Assessment and Prediction of Prospective Memory after Stroke. J Int Neuropsychol Soc. 2020;26(9):873\u201382.","journal-title":"J Int Neuropsychol Soc"},{"issue":"11","key":"1668_CR30","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/pon.3196","volume":"21","author":"TA Ahles","year":"2012","unstructured":"Ahles TA. Brain vulnerability to chemotherapy toxicities. Psycho-Oncology. 2012;21(11):1141\u20138.","journal-title":"Psycho-Oncology"},{"issue":"10","key":"1668_CR31","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/pon.3291","volume":"22","author":"H Cheng","year":"2013","unstructured":"Cheng H, Yang Z, Dong B, Chen C, Zhang M, Huang Z, Chen Z, Wang K. Chemotherapy-induced prospective memory impairment in patients with breast cancer. Psycho-Oncology. 2013;22(10):2391\u20135.","journal-title":"Psycho-Oncology"},{"issue":"2","key":"1668_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1176\/jnp.16.2.185","volume":"16","author":"RS Scheibel","year":"2004","unstructured":"Scheibel RS, Valentine AD, O\u2019Brien S, Meyers CA. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci. 2004;16(2):185\u201391.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1668_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/jnci\/djv131","volume":"107","author":"SK Patel","year":"2015","unstructured":"Patel SK, Wong AL, Wong FL, Breen EC, Hurria A, Smith M, Kinjo C, Paz IB, Kruper L, Somlo G, et al. Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer. J Nat Cancer Inst. 2015;107:8.","journal-title":"J Nat Cancer Inst"},{"key":"1668_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cancers11050687","volume":"11","author":"B Olson","year":"2019","unstructured":"Olson B, Marks DL. Pretreatment Cancer-Related Cognitive Impairment-Mechanisms and Outlook. Cancers (Basel). 2019;11:5.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1668_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2478\/jtim-2021-0050","volume":"11","author":"X Chen","year":"2023","unstructured":"Chen X, Wang M, Yu K, Xu S, Qiu P, Lyu Z, Zhang X, Xu Y. Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors. J Trans Int Med. 2023;11(3):226\u201333.","journal-title":"J Trans Int Med"},{"issue":"Suppl0","key":"1668_CR36","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.bbi.2013.01.003","volume":"30","author":"P Green McDonald","year":"2013","unstructured":"Green McDonald P, O\u2019Connell M, Lutgendorf SK. Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations. Brain, Behav, Immun. 2013;30(Suppl0):S1-9.","journal-title":"Brain, Behav, Immun"},{"key":"1668_CR37","doi-asserted-by":"crossref","unstructured":"Chu LE, Leroy AS, Fagundes CP, Murdock KW (2022) Psychoneuroimmunology and Cancer: Mechanisms Explaining Incidence, Progression, and Quality-of-Life Difficulties. In: Psychological Aspects of Cancer: A Guide to Emotional and Psychological Consequences of Cancer, Their Causes, and Their Management. edn. Edited by Steel JL, Carr BI. Cham: Springer International Publishing. pp 147-157.","DOI":"10.1007\/978-3-030-85702-8_9"},{"key":"1668_CR38","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.bbi.2012.07.015","volume":"30","author":"PA Ganz","year":"2013","unstructured":"Ganz PA, Bower JE, Kwan L, Castellon SA, Silverman DH, Geist C, Breen EC, Irwin MR, Cole SW. Does tumor necrosis factor-alpha (TNF-alpha) play a role in post-chemotherapy cerebral dysfunction? Brain Behav Immun. 2013;30:S99-108.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"1668_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/NCC.0000000000000317","volume":"39","author":"TK Mann","year":"2016","unstructured":"Mann TK, Dail RB, Bailey DE Jr. Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review. Cancer Nursing. 2016;39(5):349\u201357.","journal-title":"Cancer Nursing"},{"issue":"25","key":"1668_CR40","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1200\/JCO.2006.10.2822","volume":"25","author":"AA Tarhini","year":"2007","unstructured":"Tarhini AA, Kirkwood JM, Gooding WE, Cai C, Agarwala SS. Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy. J Clin Oncol\u202f: Off J Am Soc Clin Oncol. 2007;25(25):3802\u20137.","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"1","key":"1668_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CAD.0b013e32835a5ca3","volume":"24","author":"JC Poust","year":"2013","unstructured":"Poust JC, Woolery JE, Green MR. Management of toxicities associated with high-dose interleukin-2 and biochemotherapy. Anticancer Drugs. 2013;24(1):1\u201313.","journal-title":"Anticancer Drugs"},{"issue":"10","key":"1668_CR42","doi-asserted-by":"publisher","first-page":"e26558","DOI":"10.1371\/journal.pone.0026558","volume":"6","author":"AN Vallejo","year":"2011","unstructured":"Vallejo AN, Hamel DL Jr, Mueller RG, Ives DG, Michel JJ, Boudreau RM, Newman AB. NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PloS one. 2011;6(10):e26558.","journal-title":"PloS one"},{"key":"1668_CR43","volume-title":"Wechsler Adult Intelligence Scale - Third Edition (Chinese)","author":"JCH Chen","year":"2002","unstructured":"Chen JCH. Wechsler Adult Intelligence Scale - Third Edition (Chinese). Taipei: Chinese Behavioral Science Corp; 2002."}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01668-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-025-01668-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01668-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:25:35Z","timestamp":1757143535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-025-01668-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1668"],"URL":"https:\/\/doi.org\/10.1007\/s12282-025-01668-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4704139\/v1","asserted-by":"object"}]},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that all methods were carried out in accordance with relevant guidelines and regulations. The Institutional Review Boards from Chiayi Chang Gung Memorial Hospital approved this study (IRB numbers: 201700255B0).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Institutional Review Boards from Chiayi Chang Gung Memorial Hospital approved this study (IRB numbers: 201700255B0). We recruited adult patients with breast cancer stages I to III without brain metastasis from a medical center in Southern Taiwan between 2017 and 2021 and followed them up until they finished chemotherapy. We confirm that informed consent was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}